Literature DB >> 14668738

Negative preoperative localization studies are highly predictive of multiglandular disease in sporadic primary hyperparathyroidism.

Frederic Sebag1, Johnathan G H Hubbard, Sylvie Maweja, Claudia Misso, Laurent Tardivet, Jean-Francois Henry.   

Abstract

BACKGROUND: The development of localization studies and quick parathyroid hormone assay (QPTH) has allowed the development of focused surgery in sporadic primary hyperparathyroidism. The aim of this investigation was to determine whether localization studies select a specific population of patients.
METHODS: From 1999 to 2001, 213 patients underwent surgery for sporadic primary hyperparathyroidism. All were investigated with sestamibi scanning and ultrasonography. When at least 1 study showed a positive result (n=175), the patient underwent a video-assisted approach with QPTH. When results were negative (n=38), the patient underwent cervicotomy and exploratory procedures of all 4 parathyroid glands.
RESULTS: All patients are cured (mean follow-up, 17.8+/-10.3 months [SD]). Patients with negative preoperative study results had a high risk of multiglandular disease (12/38 patients; 31,6%), compared with patients with 1 positive study result (3/83 patients; 3.6%; P<.0001) and those with 2 concordant positive study results (0/92 patients; P<.0001).
CONCLUSION: When preoperative localization study results are negative, the patient has a high risk of multiglandular disease, and a conventional cervicotomy with identification of the 4 glands is recommended strongly. When only 1 localization study is positive, the risk of multiglandular disease justifies the use of QPTH during a focused approach. When positive localization study results are concordant, the use of QPTH is questionable during a focused approach.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14668738     DOI: 10.1016/j.surg.2003.07.021

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  31 in total

1.  Feasibility of unilateral parathyroidectomy in patients with primary hyperparathyroidism and negative or discordant localization studies.

Authors:  Pietro Giorgio Calò; Fabio Medas; Giulia Loi; Enrico Erdas; Giuseppe Pisano; Angelo Nicolosi
Journal:  Updates Surg       Date:  2016-01-29

Review 2.  How to localize parathyroid tumors in primary hyperparathyroidism?

Authors:  T Uruno; E Kebebew
Journal:  J Endocrinol Invest       Date:  2006-10       Impact factor: 4.256

3.  Technetium-99m 2-methoxyisobutyl isonitrile-scintigraphy: preoperative and intraoperative guidance for primary hyperparathyroidism.

Authors:  David R Farley
Journal:  World J Surg       Date:  2004-11-04       Impact factor: 3.352

4.  Sestamibi SPECT intensity scoring system in sporadic primary hyperparathyroidism.

Authors:  Linwah Yip; Daniel A Pryma; John H Yim; Sally E Carty; Jennifer B Ogilvie
Journal:  World J Surg       Date:  2009-03       Impact factor: 3.352

5.  Video-assisted bilateral neck exploration in patients with primary hyperparathyroidism and failed localization studies.

Authors:  Pier F Alesina; Reyaz M Singaporewalla; Martin K Walz
Journal:  World J Surg       Date:  2010-10       Impact factor: 3.352

Review 6.  The surgical management of renal hyperparathyroidism.

Authors:  Catherine Madorin; Randall P Owen; William D Fraser; Phillip K Pellitteri; Brian Radbill; Alessandra Rinaldo; Raja R Seethala; Ashok R Shaha; Carl E Silver; Matthew Y Suh; Barrie Weinstein; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-11-20       Impact factor: 2.503

7.  Actual role of color-doppler high-resolution neck ultrasonography in primary hyperparathyroidism: a clinical review and an observational study with a comparison of 99mTc-sestamibi parathyroid scintigraphy.

Authors:  Giovanni Mariano Vitetta; Alberto Ravera; Giovanni Mensa; Luca Fuso; Pierluigi Neri; Alessandro Carriero; Stefano Cirillo
Journal:  J Ultrasound       Date:  2018-10-24

8.  Should routine analysis of the MEN1 gene be performed in all patients with primary hyperparathyroidism under 40 years of age?

Authors:  Anita Skandarajah; Anne Barlier; Nathalie Morlet-Barlat; Frederic Sebag; Alain Enjalbert; Bernard Conte-Devolx; Jean-François Henry
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

Review 9.  Secondary and tertiary hyperparathyroidism, state of the art surgical management.

Authors:  Susan C Pitt; Rebecca S Sippel; Herbert Chen
Journal:  Surg Clin North Am       Date:  2009-10       Impact factor: 2.741

10.  When initial postexcision PTH level does not fall appropriately during parathyroidectomy: what to do next?

Authors:  Patrick B O'Neal; Vitaliy Poylin; Peter Mowschenson; Sareh Parangi; Gary Horowitz; Pravin Pant; Per-Olof Hasselgren
Journal:  World J Surg       Date:  2009-08       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.